Literature DB >> 23698550

Dobutamine pretreatment improves survival, liver function, and hepatic microcirculation after polymicrobial sepsis in rat.

Tobias Fink1, Paul Heymann, Stefanie Taha-Melitz, Anas Taha, Beate Wolf, Hauke Rensing, Thomas Volk, Alexander M Mathes.   

Abstract

Dobutamine is recommended for the treatment of sepsis-related circulatory failure in international guidelines. Furthermore, dobutamine has been demonstrated to improve liver function and hepatic perfusion after experimental hemorrhagic shock. Yet, it is unknown whether dobutamine may also induce hepatoprotective effects in sepsis. This study was designed to investigate the effect of dobutamine on survival, hepatic function, and microcirculation after polymicrobial sepsis in rat. Under general anesthesia, male Sprague-Dawley rats (n = 25/group) underwent pretreatment with dobutamine (10 μg/kg per minute) in the presence or absence of β1-receptor antagonist esmolol (500 μg/kg per minute), esmolol alone, or vehicle for 6 h, before induction of sepsis (cecal ligation and incision [CLI]). Sham-operated animals were treated likewise but underwent no CLI. Five hours after CLI, either liver function was assessed by plasma disappearance rate of indocyanine green (n = 5/group), or intravital microscopy was performed (n = 5/group) for evaluation of hepatic perfusion index and hepatic integrity (as propidium iodide-stained cells per field). Alternatively, survival time after induction of CLI was monitored under general anesthesia (n = 15/group). Compared with controls, dobutamine pretreatment significantly improved plasma disappearance rate of indocyanine green (13.8% ± 4.1% vs. 20.6% ± 4.6%; P = 0.029), hepatic perfusion index (275.0 ± 126.1 vs. 703.5 ± 177.4 pL/s per mm; P < 0.001), hepatocellular injury (22.2 ± 6.7 vs. 6.4 ± 3.1 cells per field; P < 0.001), and survival time (326 ± 20 vs. 603 ± 41 min; P < 0.001). Coadministration of esmolol abolished the protective effect of dobutamine completely. Our results indicate that pretreatment with dobutamine may improve survival, liver function, and hepatic microcirculation after polymicrobial sepsis in rat via β1-adrenoceptor activation. Dobutamine could therefore play a relevant role for hepatoprotection under septic conditions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23698550     DOI: 10.1097/SHK.0b013e31829c361d

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  9 in total

1.  When sepsis affects the heart: A case report and literature review.

Authors:  Giuseppe Clemente; Antonino Tuttolomondo; Daniela Colomba; Rosaria Pecoraro; Chiara Renda; Vittoriano Della Corte; Carlo Maida; Irene Simonetta; Antonio Pinto
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

2.  Surgical preparation of rats and mice for intravital microscopic imaging of abdominal organs.

Authors:  George J Rhodes
Journal:  Methods       Date:  2017-07-08       Impact factor: 3.608

Review 3.  Could Biomarkers Direct Therapy for the Septic Patient?

Authors:  Clark R Sims; Trung C Nguyen; Philip R Mayeux
Journal:  J Pharmacol Exp Ther       Date:  2016-02-08       Impact factor: 4.030

Review 4.  Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?

Authors:  Konstantinos Drosatos; Anastasios Lymperopoulos; Peter Johannes Kennel; Nina Pollak; P Christian Schulze; Ira J Goldberg
Journal:  Curr Heart Fail Rep       Date:  2015-04

Review 5.  Targeting of G-protein coupled receptors in sepsis.

Authors:  Abdul Rehman; Noor Ul-Ain Baloch; John P Morrow; Pál Pacher; György Haskó
Journal:  Pharmacol Ther       Date:  2020-03-19       Impact factor: 12.310

6.  Early administration of dobutamine in the treatment of septic shock patients with tumor-a retrospective comparative cohort study.

Authors:  Ya-Fei Wu; Yin Pan; Qiang Tang; Ning Lou; Dao-Feng Wang
Journal:  Ann Transl Med       Date:  2022-08

7.  Resveratrol therapy improves liver function via estrogen-receptors after hemorrhagic shock in rats.

Authors:  Alexander Wolf; Tobias Fink; Jochen Hinkelbein; Thilo Mertke; Thomas Volk; Alexander Mathes
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

8.  Advances in sepsis-associated liver dysfunction.

Authors:  Dawei Wang; Yimei Yin; Yongming Yao
Journal:  Burns Trauma       Date:  2014-07-28

9.  Can venous-to-arterial carbon dioxide differences reflect microcirculatory alterations in patients with septic shock?

Authors:  Gustavo A Ospina-Tascón; Mauricio Umaña; William F Bermúdez; Diego F Bautista-Rincón; Juan D Valencia; Humberto J Madriñán; Glenn Hernandez; Alejandro Bruhn; César Arango-Dávila; Daniel De Backer
Journal:  Intensive Care Med       Date:  2015-11-17       Impact factor: 17.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.